Enterin, Inc.

Denise Barbut

Michael A Zasloff

The present application relates generally to novel aminosterol compounds, compositions comprising the same, and methods of making and using the novel aminosterol compounds and compositions.

Human aminosterol ENT-03 compounds, related compositions comprising the same, and methods of using the same

The present application relates generally to methods for treating, preventing and/or slowing the onset or progression of schizophrenia and/or a related symptom. The methods comprise administering at least one aminosterol or a pharmaceutically acceptable salt or derivative thereof to a subject in need.

Aminosterol compositions and methods of using the same for treating schizophrenia

This invention relates to methods of treating or preventing a sleep disorder, sleep disturbance, or related symptom in a subject with aminosterols or pharmaceutically acceptable salts or derivatives thereof. In particular, the disclosed methods generally comprise administering an aminosterol to a subject in need, thereby stimulating an aminosterol-induced CNS response to treat and/or prevent a sleep disorder, sleep disturbance, or related symptom.

Methods for treating sleep disorders, sleep disturbances, and related symptoms using aminosterol compositions

Provided herein are crystalline solid forms of squalamine phosphate designated as Form 1 and Form 2, compositions containing one or both forms, and methods of their preparation and of their use.

Growing community of inventors

Philadelphia, PA, United States of America

Denise Barbut